Sheridan recently announced the successful closing of Sheridan Capital Partners Fund III, L.P. at the hard cap with $575 million of total capital commitments.
This Fund was oversubscribed, significantly exceeding its target of $450 million despite the challenging fundraising environment. Sheridan Capital Partners is focused on investing in lower middle market companies in recession-resistant and non-discretionary markets within the healthcare industry.
The Fund will continue Sheridan’s strategy of making control investments in North American founder-owned businesses with $3 million to $20 million of EBITDA. Sheridan is led by Partners Jonathan Lewis and Sean Dempsey.
KEY QUOTES:
“We deeply value the support we received from our existing investor base for this fundraise, as well as the new strategic partnerships we have created in Fund III, which further diversify our high-quality group of insurance companies, consultants, pensions, family offices, sovereign wealth funds and fund-of-funds across North America, Europe and the Middle East.”
— Jonathan Lewis, Partner at Sheridan
“It has been a great partnership working with Sixpoint on another successful fundraise and we’d like to thank them for their continued commitment and strategic advice. We’d also like to thank our limited partners for their critical role in closing Fund III at $575 million. We are very excited about the next phase of growth for our firm as we continue to expand both our team and presence in lower middle market healthcare.”
— Sean Dempsey, Partner at Sheridan
